Skip to main content
Midas Edge

Beyond Air, Inc.

For the period ended Dec 31, 2025. Filed Feb 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 13, 2026

XAIR$2.52+10.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Changes in Stockholders’ Equity

FOR THE THREE AND NINE MONTHS ENDED DECEMBER 31, 2025

Common Stock (1) · Treasury · Additional Paid-in · Accumulated · Accumulated Other Comprehensive (loss) · Non- Controlling · Total
Number · Amount · Stock · Capital · Deficit · Income · Interest · Equity
Balance as of April 1, 20254,128,539$-$(25)$299,990$(286,322)$(60)$758$14,341
Issuance of common stock – At The Market equity offering564,699--2,441---2,441
Issuance of common stock - 2025 Reverse Stock Split rounding46-------
Stock-based compensation---1,467--1101,577
Other comprehensive income-----127-127
Net loss----(7,691)-(387)(8,078)
Balance as of June 30, 20254,693,284$-$(25)$303,898$(294,013)$67$481$10,408
NeuroNos issuance of stock---414--86500
Issuance of warrants through September 2025 Inducement---90---90
Issuance of common stock upon exercise of warrants1,439,128--2,868---2,868
Issuance of common stock – At The Market equity offering1,877,0761-5,693---5,694
Stock-based compensation---1,662--1131,775
Other comprehensive income-----18-18
Net loss----(7,940)-(318)(8,258)
Balance as of September 30, 20258,009,488$1$(25)$314,625$(301,953)$85$362$13,095
NeuroNos issuance of stock---159--41200
Issuance of warrants---1,093---1,093
Issuance of common stock upon exercise of warrants386,361-------
Issuance of common stock upon vesting of restricted stock8,505-------
Stock-based compensation---1,437--661,503
Other comprehensive income-----25-25
Net loss----(7,336)-(294)(7,630)
Balance as of December 31, 20258,404,354$1$(25)$317,314$(309,289)$110$175$8,286

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE AND NINE MONTHS ENDED DECEMBER 31, 2024

Common Stock (1) · Treasury · Additional Paid-in · Accumulated · Accumulated Other Comprehensive (loss) · Non-Controlling · Total
Number · Amount · Stock · Capital · Deficit · Income · Interest · Equity
Balance as of April 1, 20242,295,042$-$(25)$264,785$(239,697)$(15)$2,138$27,186
Issuance of common stock warrants---86---86
Stock-based compensation---3,093--2853,379
Other comprehensive income-----103-103
Net loss----(12,201)-(854)(13,055)
Balance as of June 30, 20242,295,042$-$(25)$267,965$(251,898)$88$1,570$17,699
Sale of common stock and pre-funded warrants1,250,000--18,858---18,858
Issuance of warrants through September 2024 debt agreement---3,073---3,073
Issuance of common stock – At The Market equity offering64,341--642---642
Stock-based compensation---2,862--2683,129
Other comprehensive loss-----(79)-(79)
Net loss----(13,358)-(671)(14,029)
Balance as of September 30, 20243,609,383$-$(25)$293,398$(265,255)$9$1,167$29,294
Issuance of common stock upon exercise of warrants94,936-------
Issuance of common stock upon vesting of restricted stock12,115-------
Stock-based compensation---2,609--(129)2,480
Other comprehensive loss-----(61)-(61)
Net loss----(13,032)-(300)(13,333)
Balance as of December 31, 20243,716,434$-$(25)$296,007$(278,288)$(52)$738$18,381
(1)Prior period results have been adjusted to reflect the one-for-twenty stock split in July 2025. See Note 1, Organization and Business for details.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.